for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Genmab Announces Very Favorable Topline Results From Phase 2 Clinical Trial Of Tisotumab Vedotin

June 29 (Reuters) - Genmab A/S:

* GENMAB ANNOUNCES VERY FAVORABLE TOPLINE RESULTS FROM PHASE 2 CLINICAL TRIAL OF TISOTUMAB VEDOTIN IN RECURRENT OR METASTATIC CERVICAL CANCER

* GENMAB A/S - GENMAB, SEATTLE GENETICS PLAN TO DISCUSS PHASE 2 INNOVATV 204 RESULTS WITH U.S. FDA

* GENMAB A/S - RESULTS FROM INNOVATV 24 TRIAL SHOWED 24% CONFIRMED ORR BY INDEPENDENT CENTRAL REVIEW Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up